Charles Schwab’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.99M Buy
1,621,419
+482,472
+42% +$593K ﹤0.01% 2671
2025
Q1
$1.25M Sell
1,138,947
-103,032
-8% -$113K ﹤0.01% 2769
2024
Q4
$1.12M Buy
1,241,979
+13,902
+1% +$12.6K ﹤0.01% 2877
2024
Q3
$1.21M Sell
1,228,077
-33,520
-3% -$33.1K ﹤0.01% 2861
2024
Q2
$1.14M Buy
1,261,597
+8,833
+0.7% +$7.96K ﹤0.01% 2885
2024
Q1
$1.48M Buy
1,252,764
+32,935
+3% +$38.9K ﹤0.01% 2676
2023
Q4
$1.11M Buy
1,219,829
+139,187
+13% +$127K ﹤0.01% 2793
2023
Q3
$900K Buy
1,080,642
+651,837
+152% +$543K ﹤0.01% 2832
2023
Q2
$515K Sell
428,805
-33,892
-7% -$40.7K ﹤0.01% 3041
2023
Q1
$583K Sell
462,697
-79,358
-15% -$100K ﹤0.01% 2901
2022
Q4
$1.18M Buy
542,055
+11,870
+2% +$25.8K ﹤0.01% 2726
2022
Q3
$6.35M Buy
530,185
+132,756
+33% +$1.59M ﹤0.01% 2095
2022
Q2
$3.33M Sell
397,429
-10,126
-2% -$84.8K ﹤0.01% 2366
2022
Q1
$3.54M Buy
407,555
+17,050
+4% +$148K ﹤0.01% 2443
2021
Q4
$4.42M Buy
390,505
+7,938
+2% +$89.8K ﹤0.01% 2407
2021
Q3
$4.81M Buy
382,567
+20,237
+6% +$254K ﹤0.01% 2395
2021
Q2
$2.94M Buy
362,330
+42,330
+13% +$344K ﹤0.01% 2592
2021
Q1
$2.96M Sell
320,000
-17,215
-5% -$159K ﹤0.01% 2537
2020
Q4
$3.26M Buy
337,215
+606
+0.2% +$5.86K ﹤0.01% 2428
2020
Q3
$4.18M Buy
336,609
+10,615
+3% +$132K ﹤0.01% 2160
2020
Q2
$4.24M Buy
325,994
+78,687
+32% +$1.02M ﹤0.01% 2100
2020
Q1
$2.51M Buy
247,307
+4,499
+2% +$45.7K ﹤0.01% 2180
2019
Q4
$3.8M Buy
242,808
+4,154
+2% +$64.9K ﹤0.01% 2168
2019
Q3
$4.01M Buy
238,654
+131,013
+122% +$2.2M ﹤0.01% 2090
2019
Q2
$2.39M Buy
107,641
+22,368
+26% +$496K ﹤0.01% 2311
2019
Q1
$1.85M Buy
+85,273
New +$1.85M ﹤0.01% 2388